Diagnosing Lyme disease has always been a problem, as many of the symptoms are similar to a whole host of other conditions and traditional serological testing methods are unreliable in the early stages. Doctors have to rely on combining a list of symptoms with identifying the risks of patient exposure to ticks (which carry the bacteria responsible for Lyme disease), and as this condition can incubate in the body for months or even years before it manifests this can make diagnosis even more difficult.
A recent report published in the latest April 2010 edition of the American Journal of Clinical Pathology may bring some hope to medical staff dealing with Lyme disease around the world, as a team at the Milford Hospital, CT (headed by Connecticut physician Sin Hang Lee, MD) have now revealed a new way of diagnosing this disease by using DNA testing to identify whether or not the patient has any of the bacteria which cause Lyme disease present in their blood. In clinical testing this DNA procedure proved to be highly successful at identifying low levels of the Lyme bacteria, which were often missed by the previous methods of serological testing.
Early Lyme Diagnosis
Lyme disease can easily be treated in the early stages by using standard antibiotics, but if left untreated this bacteria can spread through the body causing a whole host of painful and potentially debilitating conditions such as Lyme arthritis, chronic fatigue and even serious problems with the central nervous system and heart such as neuro borrelia and arrhythmia. This is why it is so important to diagnose Lyme disease as quickly as possible, as it can save months of unnecessary pain and discomfort for patients and can prevent any serious complications from developing.
The DNA test discovered by the Connecticut research team is highly sensitive and specifically aimed at identifying Lyme disease, and is most effective in the early stages of the condition when the bacteria are circulating freely in the blood system. Several leading medical insurance companies have already recognized the potential of this new testing method and have provisionally agreed to cover the costs of this procedure for their members.
What Causes Lyme Disease?
Lyme disease is spread by the bite of infected black legged ticks, which are common in many areas of Europe and throughout the mid and eastern United States. Lyme disease is caused by the Borrelia burgdorferi bacteria which is transmitted through tick saliva into the body of the host, where it typically has an incubation period of around 3 to 30 days (although it has been known to remain undetected for years before manifesting symptoms in the host). The Lyme bacteria infection can spread through the body via the blood stream and also lymph nodes, and can be carried to major organs and other areas of the skin.
As well as preventing under-diagnosis of Lyme disease and ensuring that sufferers are treated as quickly as possible this new DNA technique could also help to prevent over-diagnosis of this condition, and this can reduce the unnecessary use of strong antibiotics in patients who have been misdiagnosed with Lyme disease.


















